BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9249003)

  • 1. Cleavage requirements for activation of factor V by factor Xa.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Eur J Biochem; 1997 Jul; 247(1):12-20. PubMed ID: 9249003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of factor V by cathepsin G and elastase indicates that cleavage at Arg1545 optimizes cofactor function by facilitating factor Xa binding.
    Camire RM; Kalafatis M; Tracy PB
    Biochemistry; 1998 Aug; 37(34):11896-906. PubMed ID: 9718313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage requirements of factor V in tissue-factor induced thrombin generation.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Thromb Haemost; 1998 Jul; 80(1):92-8. PubMed ID: 9684792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin-catalyzed activation of recombinant human factor V.
    Keller FG; Ortel TL; Quinn-Allen MA; Kane WH
    Biochemistry; 1995 Mar; 34(12):4118-24. PubMed ID: 7696276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human neutrophil elastase activates human factor V but inactivates thrombin-activated human factor V.
    Samis JA; Garrett M; Manuel RP; Nesheim ME; Giles AR
    Blood; 1997 Aug; 90(3):1065-74. PubMed ID: 9242537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural requirements for expression of factor Va activity.
    Kalafatis M; Beck DO; Mann KG
    J Biol Chem; 2003 Aug; 278(35):33550-61. PubMed ID: 12788947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: an insight into the APC-resistance assay.
    Kalafatis M; Haley PE; Lu D; Bertina RM; Long GL; Mann KG
    Blood; 1996 Jun; 87(11):4695-707. PubMed ID: 8639839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .
    Hirbawi J; Vaughn JL; Bukys MA; Vos HL; Kalafatis M
    Biochemistry; 2010 Oct; 49(39):8520-34. PubMed ID: 20722419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of human factor V by factor Xa and thrombin.
    Monkovic DD; Tracy PB
    Biochemistry; 1990 Feb; 29(5):1118-28. PubMed ID: 2322551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms that regulate the anticoagulant function of coagulation factor V.
    Thorelli E
    Scand J Clin Lab Invest Suppl; 1999; 229():19-26. PubMed ID: 10097286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V C2 domain contains a major thrombin-binding site responsible for thrombin-catalyzed factor V activation.
    Suzuki H; Shima M; Nogami K; Sakurai Y; Nishiya K; Saenko EL; Tanaka I; Yoshioka A
    J Thromb Haemost; 2006 Jun; 4(6):1354-60. PubMed ID: 16706982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The factor V B-domain provides two functions to facilitate thrombin cleavage and release of the light chain.
    Marquette KA; Pittman DD; Kaufman RJ
    Blood; 1995 Oct; 86(8):3026-34. PubMed ID: 7579396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor VIIa/tissue factor generates a form of factor V with unchanged specific activity, resistance to activation by thrombin, and increased sensitivity to activated protein C.
    Safa O; Morrissey JH; Esmon CT; Esmon NL
    Biochemistry; 1999 Feb; 38(6):1829-37. PubMed ID: 10026263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The factor V activation paradox.
    Orfeo T; Brufatto N; Nesheim ME; Xu H; Butenas S; Mann KG
    J Biol Chem; 2004 May; 279(19):19580-91. PubMed ID: 14982929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteolysis of factor Va by factor Xa and activated protein C.
    Odegaard B; Mann K
    J Biol Chem; 1987 Aug; 262(23):11233-8. PubMed ID: 3611108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of bovine factor V by an activator purified from the venom of Naja naja oxiana.
    Gerads I; Tans G; Yukelson LYa ; Zwaal RF; Rosing J
    Toxicon; 1992 Sep; 30(9):1065-79. PubMed ID: 1440644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation factor V: a plethora of anticoagulant molecules.
    Kalafatis M
    Curr Opin Hematol; 2005 Mar; 12(2):141-8. PubMed ID: 15725905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of thrombin exosites I and II in the activation of human coagulation factor V.
    Segers K; Dahlbäck B; Bock PE; Tans G; Rosing J; Nicolaes GA
    J Biol Chem; 2007 Nov; 282(47):33915-24. PubMed ID: 17878169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.